4Shalev A, Harmesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiat, 1989,50 (I) :18 -25.
5Pope H, Keck P, MeElroy S. Frequency and presentation of neuroleptie malignant syndrome in a large psychiatric hospital. Am J Psychiat,1986, 143(10) :1227 - 1233.
6Hasan S, Buckley P. Novel Antipsychotics and the neuroleptic malignant syndrome: a review and critique. Am J Psychiat, 1998, 155 (8) :1113 - 1116.
7Strawn JR. Aripiprazole and the neuroleptic malignant syndrome. Schizophr Res, 2006,85 ( 1 - 3 ) : 298 - 299.
8Sachdev PS. A rating scale for neuroleptic malignant syndrome. Psychiatry Res, 2005,135 (3) :249 - 256.
9Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiat,2007,164 (6) : 870 - 876.
10Chandran GJ, Mikler JR, Keegan DL. Neuroleptic malignant syndrome: case report and discussion. CMAJ, 2003, 169 (5):439 - 442.
2DELAY J,PICHOT P,LEMPERIERE T,ELISSALDE B,PEIGNE F.(A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses)Annales médico-psychologiques . 1960
3Levenson J L.Neuroleptic malignant syndrome. The American journal of psychiatry . 1985